Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 57

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 57
---
,066Other long-term liabilities3,0532,332Total finance lease liabilities$4,588$3,398Weighted-Average Remaining Lease TermFinance leases3.2 years3.5 yearsWeighted-Average Discount RateFinance leases5.96 %5.63 %            As of June 30, 2025, the maturities of our operating and finance lease liabilities for each of the next five years and thereafter are approximately (in thousands):Operating LeasesFinance LeasesRemainder of 2025$8,207 $911 202614,802 1,691 202712,305 1,311 20289,660 823 20297,830 248 20304,562 47 Thereafter16,686 — Total Lease Payments74,052 5,031 Less imputed interest(11,420)(443)Total$62,632 $4,588 

Note 8:    Net Income (Loss) Per Share

 Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. A net loss for the three and six months ended June 30, 2024 causes all of the potentially dilutive common shares to be antidilutive and, accordingly, they were not included in the computation of diluted earnings per share, and basic and diluted net loss per share are equal for each of these periods.    The following table presents the calculation of net earnings per common share (“EPS”) — basic and diluted (in thousands, except per share data):  

19

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

 Three months ended June 30,Six months ended June 30, 2025202420252024Net income (loss)$35,338 $(21,406)$19,862